Clinical Trials

  • Principal Investigator

    Elizabeth C. Oelsner, MD, MPH
    If you currently live in the same household as someone who has tested positive for novel coronavirus (COVID-19), you might be eligible to participate in a trial that will test if a medicine used to prevent malaria, hydroxychloroquine, might reduce the risk of your developing COVID-19 symptoms. COVID-19 is a massive threat to public health worldwide.
  • The purpose of NOMEM is to learn more about how blood sugar and other factors relate to the brain and mental abilities of persons living in Northern Manhattan. We are seeking your help to conduct this study. Participation will include these activities: 1. Questionnaires 2. Blood tests 3. A brain MRI 4. A brain PET scan with contrast. We will compensate your time for participating in these 4 activities with $350. We will also give you the results of important blood tests.